These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19422140)

  • 21. Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.
    Vlassara H; Cai W; Tripp E; Pyzik R; Yee K; Goldberg L; Tansman L; Chen X; Mani V; Fayad ZA; Nadkarni GN; Striker GE; He JC; Uribarri J
    Diabetologia; 2016 Oct; 59(10):2181-92. PubMed ID: 27468708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromium picolinate supplementation in women: effects on body weight, composition, and iron status.
    Lukaski HC; Siders WA; Penland JG
    Nutrition; 2007 Mar; 23(3):187-95. PubMed ID: 17291720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplementation with Low Doses of a Cod Protein Hydrolysate on Glucose Regulation and Lipid Metabolism in Adults with Metabolic Syndrome: A Randomized, Double-Blind Study.
    Jensen C; Fjeldheim Dale H; Hausken T; Hatlebakk JG; Brønstad I; Lied GA; Hoff DAL
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of chromium picolinate on glucose and lipid metabolism in running rats.
    Pala R; Sari MA; Erten F; Er B; Tuzcu M; Orhan C; Deeh PBD; Sahin N; Cinar V; Komorowski JR; Sahin K
    J Trace Elem Med Biol; 2020 Mar; 58():126434. PubMed ID: 31778961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial.
    Demidowich AP; Levine JA; Onyekaba GI; Khan SM; Chen KY; Brady SM; Broadney MM; Yanovski JA
    Diabetes Obes Metab; 2019 Jul; 21(7):1642-1651. PubMed ID: 30869182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.
    Koska J; Ortega E; Bunt JC; Gasser A; Impson J; Hanson RL; Forbes J; de Courten B; Krakoff J
    Diabetologia; 2009 Mar; 52(3):385-93. PubMed ID: 19104769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Synbiotic Supplementation on Body Mass Index, Metabolic and Inflammatory Biomarkers, and Appetite in Patients with Metabolic Syndrome: A Triple-Blind Randomized Controlled Trial.
    Rabiei S; Hedayati M; Rashidkhani B; Saadat N; Shakerhossini R
    J Diet Suppl; 2019; 16(3):294-306. PubMed ID: 29672196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance.
    Risérus U; Basu S; Jovinge S; Fredrikson GN; Arnlöv J; Vessby B
    Circulation; 2002 Oct; 106(15):1925-9. PubMed ID: 12370214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin.
    Sahin K; Tuzcu M; Orhan C; Sahin N; Kucuk O; Ozercan IH; Juturu V; Komorowski JR
    Br J Nutr; 2013 Jul; 110(2):197-205. PubMed ID: 23211098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Response to Mulberry Extract Supplementation in Patients With Diabetic Nephropathy: a Randomized Controlled Trial.
    Taghizadeh M; Soleimani A; Bahmani F; Moravveji A; Asadi A; Amirani E; Farzin N; Sharifi N; Naseri A; Dastorani M; Asemi Z
    Iran J Kidney Dis; 2017 Nov; 11(6):438-446. PubMed ID: 29190604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome.
    Belfort R; Berria R; Cornell J; Cusi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):829-36. PubMed ID: 20061429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program.
    Volpe SL; Huang HW; Larpadisorn K; Lesser II
    J Am Coll Nutr; 2001 Aug; 20(4):293-306. PubMed ID: 11506057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of chromium tripicolinate on glucose metabolism and nutrient partitioning in growing lambs.
    Kitchalong L; Fernandez JM; Bunting LD; Southern LL; Bidner TD
    J Anim Sci; 1995 Sep; 73(9):2694-705. PubMed ID: 8582860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
    Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
    J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.
    Sahin K; Onderci M; Tuzcu M; Ustundag B; Cikim G; Ozercan IH; Sriramoju V; Juturu V; Komorowski JR
    Metabolism; 2007 Sep; 56(9):1233-40. PubMed ID: 17697867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial.
    Geohas J; Daly A; Juturu V; Finch M; Komorowski JR
    Am J Med Sci; 2007 Mar; 333(3):145-53. PubMed ID: 17496732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Influences of Chromium Supplementation on Glycemic Control, Markers of Cardio-Metabolic Risk, and Oxidative Stress in Infertile Polycystic ovary Syndrome Women Candidate for In vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Zadeh Modarres S; Amiri Siavashani M; Karimi M; Mafi A; Ostadmohammadi V; Asemi Z
    Biol Trace Elem Res; 2018 Sep; 185(1):48-55. PubMed ID: 29307112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromium picolinate modulates serotonergic properties and carbohydrate metabolism in a rat model of diabetes.
    Komorowski JR; Tuzcu M; Sahin N; Juturu V; Orhan C; Ulas M; Sahin K
    Biol Trace Elem Res; 2012 Oct; 149(1):50-6. PubMed ID: 22434381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of N-Acetylcysteine on Metabolic Profile in Metabolic Syndrome Patients.
    Rani M; Aggarwal R; Vohra K
    Metab Syndr Relat Disord; 2020 Sep; 18(7):341-346. PubMed ID: 32552298
    [No Abstract]   [Full Text] [Related]  

  • 40. Study Protocol for a Randomized Controlled Trial Evaluating the Effectof Chromium Picolinate Supplementation on Gene Expression of TumorNecrosis Factor-α and DNA Damage in Metabolic Syndrome Patients.
    Mozaffari-Khosravi H; Jambarsan S; Karimpour F; Hosseini SE; Kour BE
    Saudi J Kidney Dis Transpl; 2021; 32(6):1671-1678. PubMed ID: 35946280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.